Cyclopharm Ltd has released a press release.
CYC Achieves USFDA Agreement For Technegas Trial Design
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cyclopharm
- Cyclopharm Business Update on Significant Milestones
- Appendix 4D and Half Year Accounts
- CYC Signs Agreement with the Canadian Association of Nuc Med
- Trading Update & Record Technegas Order Received from China
- Cyclopharm to Proceed Independently with FDA Trials
Later from Cyclopharm
- CYC 2016 preliminary headline update-record results
- Cyclopharm Amended 2016 Preliminary Financial Report
- CYC - Positive Results of China Clinical Trial
- Entitlement Offer
- CYC Entitlement Offer Booklet
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm